Spleen volume was linked with an increased risk of IBD in a Mendelian randomization study. (Scientific Reports) A dual ...

That study included 123 patients, 83 of whom got vimseltinib and 40 of whom got a placebo. The investigators reported that 67 ...

This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...

Discover Vimseltinib, the newly FDA-approved treatment for tenosynovial giant cell tumor (TGCT). Learn about its benefits, ...

The Human Tumor Atlas Network leverages scientific collaboration to integrate samples, analytical modalities and tools into detailed atlases of tumor evolution. Expanding our spatial understanding ...

Select the journal/section where you want your idea to be submitted: This Research Topic is the second volume of the “Tertiary Lymphoid Structures (TLS) in the Tumor Immune Microenvironment” Community ...

When people undergo radiotherapy for cancer, it's not just the tumor that suffers. The radiation causes DNA breaks in healthy ...

Updated TIDE-A study findings show that maintenance Bavencio with Inlyta treatment interruption is feasible in patients with ...

A groundbreaking study shows findings that show a treatment can shrink tumors and improve survival outcomes for patients with ...